Global Injectable Anticoagulants Market Study 2015-2025, by Segment (Low-molecular-weight Heparin (LMWH), Direct Thrombin Inhibitor (DTI), Others), by Market (VTE, ACS/MIDirect Thrombin Inhibitor (DTI), AF), by Company (Genentech (Roche), Sanofi, Boehringer Ingelheim)
ReportPage
Report ID
43960
Published Date
24-Sep
No of Report Page
65
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin ], enoxaparin [Lovenox ]) and factor Xa inhibitors (fondaparinux [Arixtra ]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism.
    
The global Injectable Anticoagulants market will reach xxx Mil
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Injectable Anticoagulants Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Injectable Anticoagulants Market by Type
    
    2.1 By Type
    
       2.1.1 Low-molecular-weight Heparin (LMWH)
    
       2.1.2 Direct Thrombin
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -